News tagged with lipitor
Cholesterol drugs might boost kidney cancer survival
(HealthDay)—Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Pfizer Q1 profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Other
Apr 30, 2013 |
not rated yet |
0
U-M researchers find new way to clear cholesterol from the blood
Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins.
Cardiology
Apr 10, 2013 |
5 / 5 (1) |
0
|
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other
Jan 29, 2013 |
not rated yet |
0
Drugmaker Ranbaxy halts generic Lipitor production
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Medications
Nov 30, 2012 |
not rated yet |
0
Study links improved consumer welfare to increased prescription drug advertising efforts
More people are better off thanks to the impact of an influx of direct-to-consumer advertising spending than they would be without those marketing efforts, according to a study recently published by Jayani Jayawardhana, an ...
Medications
Nov 26, 2012 |
not rated yet |
0
Ranbaxy recalls generic Lipitor doses
(AP)—Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once ...
Medications
Nov 23, 2012 |
not rated yet |
0
Pfizer 3Q profit falls 14 pct on generic Lipitor (Update)
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Other
Nov 01, 2012 |
not rated yet |
0
Pfizer 2Q net income rises 25 pct on lower costs
Drugmaker Pfizer Inc.'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor ...
Other
Jul 31, 2012 |
not rated yet |
0
Retailers sue Pfizer, charge generic Lipitor delay
(AP) — Five large U.S. drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.
Medications
Jul 07, 2012 |
not rated yet |
0
Statins may help prevent irregular heartbeat in elderly
(HealthDay) -- The widely used class of cholesterol-lowering medications known as statins may help elderly patients with high blood pressure avoid developing atrial fibrillation, a heart rhythm abnormality ...
Cardiology
May 10, 2012 |
not rated yet |
0
|
FDA adds new safety information to statin drugs
(AP) -- Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, a widely prescribed group of cholesterol-lowering medications.
Medications
Feb 28, 2012 |
not rated yet |
0
Counterfeit drugs becoming big business worldwide
(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly ...
Medications
Feb 16, 2012 |
5 / 5 (1) |
1
With new generic rivals, Lipitor's sales halved
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Medications
Dec 20, 2011 |
not rated yet |
3
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Atorvastatin
Atorvastatin (INN) ( /əˌtɔrvəˈstætən/), sold by Pfizer under the trade name Lipitor, is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammatory and other mechanisms. Like all statins, atorvastatin works by inhibiting HMG-CoA reductase, an enzyme found in liver tissue that plays a key role in production of cholesterol in the body.
Atorvastatin was first synthesized in 1985 by Bruce Roth while working at Parke-Davis Warner-Lambert Company (now Pfizer). With 2008 sales of US$12.4 billion, Lipitor was the top-selling branded pharmaceutical in the world. U.S. patent protection was scheduled to expire in June 2011. However, Pfizer made an agreement with Ranbaxy Laboratories to delay the generic launch in the U.S. until November 30, 2011.
For more information about Atorvastatin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
